Citadel Advisors - UNITED THERAPEUTICS CORP DEL ownership

UNITED THERAPEUTICS CORP DEL's ticker is and the CUSIP is 91307CAF9. A total of 20 filers reported holding UNITED THERAPEUTICS CORP DEL in Q3 2014. The put-call ratio across all filers is - and the average weighting 1.8%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of UNITED THERAPEUTICS CORP DEL
ValueSharesWeighting
Q3 2014$62,090,000
+43.2%
22,998,0000.0%0.06%
+30.0%
Q2 2014$43,366,000
+21.4%
22,998,000
+27.8%
0.05%
+19.0%
Q1 2014$35,733,000
+15.8%
17,998,000
+38.5%
0.04%
+5.0%
Q4 2013$30,845,000
+39.6%
12,998,0000.0%0.04%
+17.6%
Q3 2013$22,097,000
-25.2%
12,998,000
-36.0%
0.03%
-33.3%
Q2 2013$29,546,00020,305,0000.05%
Other shareholders
UNITED THERAPEUTICS CORP DEL shareholders Q3 2014
NameSharesValueWeighting ↓
Sage Capital Management, LLC 2,500,000$4,245,0004.05%
WHITEBOX ADVISORS LLC 34,365,000$58,350,0003.08%
BASSO CAPITAL MANAGEMENT, L.P. 10,000,000$16,963,0002.96%
CAMDEN ASSET MANAGEMENT L P /CA 21,257,000$36,084,0002.17%
GRACE BROTHERS MANAGEMENT LLC 1,500,000$2,549,0002.17%
Ferox Capital Management LP 3,000,000$5,101,0001.96%
Castle Creek Arbitrage, LLC 20,700,000$35,185,0001.57%
Polar Asset Management Partners Inc. 20,000,000$34,012,0001.44%
SYMPHONY ASSET MANAGEMENT LLC 7,712,000$13,091,0001.33%
Verition Fund Management LLC 2,500,000$4,256,0000.64%
View complete list of UNITED THERAPEUTICS CORP DEL shareholders